当前位置: 首页 >> 检索结果
共有 254 条符合本次的查询结果, 用时 2.4403177 秒

141. Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis.

作者: William S Yancy.;Douglas C McCrory.;Remy R Coeytaux.;Kristine M Schmit.;Alex R Kemper.;Adam Goode.;Victor Hasselblad.;Brooke L Heidenfelder.;Gillian D Sanders.
来源: Chest. 2013年144卷6期1827-1838页
Understanding the comparative effectiveness of treatments for patients with unexplained or refractory cough is important to increase awareness of proven therapies and their potential adverse effects in this unique population.

142. Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis.

作者: George Dimopoulos.;Garyphallia Poulakou.;Ioannis A Pneumatikos.;Apostolos Armaganidis.;Marin H Kollef.;Dimitrios K Matthaiou.
来源: Chest. 2013年144卷6期1759-1767页
We performed a systematic review and meta-analysis of short- vs long-duration antibiotic regimens for ventilator-associated pneumonia (VAP).

143. Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis.

作者: Abhishek Sharma.;Saurav Chatterjee.;Armin Arbab-Zadeh.;Sandeep Goyal.;Edgar Lichstein.;Joydeep Ghosh.;Shamik Aikat.
来源: Chest. 2013年144卷4期1311-1322页
Clinical studies have suggested an association between bisphosphonate use and the onset of atrial fibrillation (AF). However, data on the risk of developing AF, stroke, and cardiovascular mortality with the use of bisphosphonate are conflicting. The objective of this study was to evaluate the risk of serious AF (events that required hospital admission), stroke, and cardiovascular mortality with the use of bisphosphonates through a systematic review of the literature.

144. Relative effects of two different enoxaparin regimens as comparators against newer oral anticoagulants: meta-analysis and adjusted indirect comparison.

作者: Chun Shing Kwok.;Shiva Pradhan.;Jessica Ka-Yan Yeong.;Yoon K Loke.
来源: Chest. 2013年144卷2期593-600页
Two different regimens of enoxaparin (40 mg once daily or 30 mg bid) have been used as control arms in trials of new oral anticoagulants. The choice of enoxaparin comparator may influence the perceived relative efficacy and safety of the newer agents, and we aimed to identify any significant differences between the two enoxaparin regimens.

145. Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials.

作者: Damien Barraud.;Pierre-Edouard Bollaert.;Sébastien Gibot.
来源: Chest. 2013年143卷3期646-655页
The objective of this study was to systematically review and quantitatively synthesize all randomized controlled trials (RCTs) that have compared important outcomes in critically ill patients who received an administration of probiotics.

146. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis.

作者: Evan Atlantis.;Paul Fahey.;Belinda Cochrane.;Sheree Smith.
来源: Chest. 2013年144卷3期766-777页
The longitudinal associations between depression or anxiety and COPD, and their comorbid effect on prognosis, have not been adequately addressed by previous reviews. We aimed to systematically assess these associations to inform guidelines and practice.

147. Simulation-based bronchoscopy training: systematic review and meta-analysis.

作者: Cassie C Kennedy.;Fabien Maldonado.;David A Cook.
来源: Chest. 2013年144卷1期183-192页
Simulation-based bronchoscopy training is increasingly used, but effectiveness remains uncertain. We sought to perform a comprehensive synthesis of published work on simulation-based bronchoscopy training.

148. Lack of efficacy of probiotics in preventing ventilator-associated pneumonia probiotics for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials.

作者: Wan-Jie Gu.;Chun-Yin Wei.;Rui-Xing Yin.
来源: Chest. 2012年142卷4期859-868页
Ventilator-associated pneumonia (VAP) remains a common hazardous complication in patients who are mechanically ventilated and is associated with increased morbidity and mortality.We undertook a systematic review and meta-analysis of randomized controlled trials to evaluate the efficacy and safety of probiotics for the prevention of VAP.

149. Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis.

作者: Bhavneesh K Sharma.;Jessie P Bakker.;David G McSharry.;Akshay S Desai.;Shahrokh Javaheri.;Atul Malhotra.
来源: Chest. 2012年142卷5期1211-1221页
Adaptive servoventilation (ASV) has demonstrated efficacy in treating sleep-disordered breathing (SDB) in patients with heart failure (HF), but large randomized trials are lacking. We, therefore, sought to perform a systematic review and meta-analysis of existing data.

150. Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses.

作者: Ravi K Viswanathan.;William W Busse.
来源: Chest. 2012年141卷5期1303-1314页
Allergen-specific immunotherapy (SIT) involves the repeated administration of allergenic extracts to atopic individuals over a period of 3 to 5 years either subcutaneously (SCIT) or sublingually (SLIT) for the treatment of allergic respiratory diseases, including asthma and allergic rhinitis (AR). In studies, SCIT and SLIT have been shown to improve existing symptoms of asthma and AR and to also have the capability to cause disease-modifying changes of the underlying atopic condition so as to prevent new allergic sensitization as well as arrest progression of AR to asthma. Recent evidence suggests that immunotherapy brings about these effects through actions that use T-regulatory cells and blocking antibodies such as IgG(4) and IgA(2,) which can then result in an "immune deviation" from a T-helper (Th) 2 cell pattern to a Th1 cell pattern. Numerous meta-analyses and studies have been performed to evaluate the existing data among these studies, with the consensus recommendation favoring the use of immunotherapy because of its potential to modify existing diseases. Significant adverse reactions can occur with immunotherapy, including anaphylaxis and, very rarely, death. A primary factor in considering SIT is its potential to provide long-lasting effects that are able to be sustained well after its discontinuation. Given the significant burden these allergic diseases impose on the health-care system, SIT appears to be a cost-effective adjunctive treatment in modifying the existing disease state.

151. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis.

作者: Roland Diel.;Robert Loddenkemper.;Albert Nienhaus.
来源: Chest. 2012年142卷1期63-75页
Given the current lack of effective vaccines against TB, the accuracy of screening tests for determining or excluding latent TB infection (LTBI) is decisive in effective TB control. This meta-analysis critically appraises studies investigating the positive and the negative predictive value (PPV and NPV, respectively) from a test-determined LTBI state for progression to active TB of interferon-γ release assays (IGRAs) and the tuberculin skin test (TST).

152. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis.

作者: Surinder Janda.;John Swiston.
来源: Chest. 2012年142卷2期401-411页
The purpose of our study was to conduct a systematic review and meta-analysis of all randomized controlled trials to date comparing fibrinolytics with placebo to clarify their current role in the management of parapneumonic effusions and empyemas.

153. Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials.

作者: Jacqueline M Cohen.;Elie A Akl.;Susan R Kahn.
来源: Chest. 2012年141卷2期308-320页
Postthrombotic syndrome (PTS) is a frequent, chronic complication of DVT. The effectiveness and safety of available treatments are unknown. The objective of this study was to systematically review the literature to assess whether pharmacologic and compression therapies are effective and safe for the treatment of PTS.

154. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis: a meta-analysis of observational studies.

作者: Ajmal Khan.;Ritesh Agarwal.;Ashutosh N Aggarwal.
来源: Chest. 2012年141卷5期1273-1283页
Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare pulmonary disease caused by functional deficiency of granulocyte-macrophage colony-stimulating factor (GM-CSF). Administration of GM-CSF represents a potential therapeutic strategy in management of aPAP. Herein, we systematically review the efficacy of GM-CSF therapy in aPAP.

155. Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule.

作者: Jessica S Wang Memoli.;Paul J Nietert.;Gerard A Silvestri.
来源: Chest. 2012年142卷2期385-393页
The detection of pulmonary nodules (PNs) is likely to increase, especially with the release of the National Lung Screen Trials. When tissue diagnosis is desired, transthoracic needle aspiration (TTNA) is recommended. Several guided-bronchoscopy technologies have been developed to improve the yield of transbronchial biopsy for PN diagnosis: electromagnetic navigation bronchoscopy (ENB), virtual bronchoscopy (VB), radial endobronchial ultrasound (R-EBUS), ultrathin bronchoscope, and guide sheath. We undertook this meta-analysis to determine the overall diagnostic yield of guided bronchoscopy using one or a combination of the modalities described here.

156. The timing of tracheotomy in critically ill patients undergoing mechanical ventilation: a systematic review and meta-analysis of randomized controlled trials.

作者: Fei Wang.;Youping Wu.;Lulong Bo.;Jingsheng Lou.;Jiali Zhu.;Feng Chen.;Jinbao Li.;Xiaoming Deng.
来源: Chest. 2011年140卷6期1456-1465页
The objective of this study was to systematically review and quantitatively synthesize all randomized controlled trials (RCTs), comparing important outcomes in ventilated critically ill patients who received an early or late tracheotomy.

157. Test characteristics of ultrasonography for the detection of pneumothorax: a systematic review and meta-analysis.

作者: Khaled Alrajhi.;Michael Y Woo.;Christian Vaillancourt.
来源: Chest. 2012年141卷3期703-708页
A pneumothorax is a potentially life-threatening condition. Although CT scan is the reference standard for diagnosis, chest radiographs are commonly used to rule out the diagnosis. We compared the test characteristics of ultrasonography and supine chest radiography in adult patients clinically suspected of having a pneumothorax, using CT scan or release of air on chest tube placement as reference standard.

158. Diagnosis of pneumothorax by radiography and ultrasonography: a meta-analysis.

作者: Wu Ding.;Yuehong Shen.;Jianxin Yang.;Xiaojun He.;Mao Zhang.
来源: Chest. 2011年140卷4期859-866页
This study compares, by meta-analysis, the use of anterior-posterior chest radiography (CR) with transthoracic ultrasonography for the diagnosis of pneumothorax.

159. Assessing evidence of interaction between smoking and warfarin: a systematic review and meta-analysis.

作者: Surakit Nathisuwan.;Piyameth Dilokthornsakul.;Nathorn Chaiyakunapruk.;Tatiya Morarai.;Thararat Yodting.;Nichakorn Piriyachananusorn.
来源: Chest. 2011年139卷5期1130-1139页
Chronic smoking, theoretically, can interfere with warfarin metabolism through enzyme-inducing effects of polycyclic aromatic hydrocarbons. However, clinical evidence of interactions between warfarin and smoking are inconclusive. This study aimed to systematically review all relevant clinical evidence of this interaction.

160. Maintenance therapy with continuous or switch strategy in advanced non-small cell lung cancer: a systematic review and meta-analysis.

作者: Xinji Zhang.;Jiajie Zang.;Jinfang Xu.;Chong Bai.;Yingyi Qin.;Ke Liu.;Cheng Wu.;Meijing Wu.;Qian He.;Shanshan Zhang.;Lixin Wei.;Jia He.
来源: Chest. 2011年140卷1期117-126页
Maintenance therapy for patients with non-small cell lung cancer (NSCLC) has gained extensive interest. Varying results for this treatment underpin the need for a synthesis of evidence.
共有 254 条符合本次的查询结果, 用时 2.4403177 秒